Litigation Details for MSN Laboratories Private Limited v. Bioprojet Societe Civile De Recherche (E.D. Va. 2023)
✉ Email this page to a colleague
MSN Laboratories Private Limited v. Bioprojet Societe Civile De Recherche (E.D. Va. 2023)
Docket | ⤷ Sign Up | Date Filed | 2023-12-08 |
Court | District Court, E.D. Virginia | Date Terminated | 2024-01-12 |
Cause | 35:1 Patent Non-Infringement - Declaratory Judgment | Assigned To | Claude M. Hilton |
Jury Demand | None | Referred To | William E. Fitzpatrick |
Patents | 8,207,197; 8,354,430; 8,486,947 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in MSN Laboratories Private Limited v. Bioprojet Societe Civile De Recherche
Details for MSN Laboratories Private Limited v. Bioprojet Societe Civile De Recherche (E.D. Va. 2023)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2023-12-21 | 15 | United States Patent Nos. 8,486,947 (“the ’947 patent”); 8,207,197 (“the ’197 patent”); and 8,354,430…judicial district in which comprehensive patent litigation on these patents is pending. The factors courts…,430 (“the ’430 patent) (collectively, “the patents-in-suit”) are listed in FDA’s Approved Drug Products…expiration of the patents-in-suit. MSN seeks a declaratory judgment that the patents-in-suit 2 All…Book-listed patent covering the brand name drug has expired, that filer must certify the patent is invalid | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |